Wikipedia -WSS

Wikipedia

author：explore 2025-10-01 05:38:46 - browse：53576

Medicare generally pays far more for CAR-T drugs that are administered in outpatient departments than it does for inpatient care. Adobe

WASHINGTON — Hospitals for years have complained that Medicare pays so little for CAR-T cancer treatments that they sometimes lose money administering the incredibly expensive treatments. But that could soon change: if drug companies succeed in making the cancer treatments safer, hospitals could provide them more often in outpatient departments, where payment is higher.

CAR-T uses the body’s own immune system to kill cancerous cells. The procedure, regulated as a drug, involves taking T cells from a patient’s blood, adding chimeric antigen receptors (CAR) to the T cells that kill cancer, and injecting the CAR-T treatment back into the patient.

It’s worked wonders in many cancer patients who have run out of options. But right now it’s almost exclusively administered in hospitals, because the side effects can require aggressive treatments. In many cases, the CAR-T cells trigger immune reactions that can be life-threatening.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： CDC director unscathed in first congressional testimony

WSS

Akero's treatment for NASH falls short in cirrhosis study

UnitedHealth’s Optum accused of antitrust violations in California

Despite FDA concern, risk that CAR

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

STAT Readout: Today's biotech news includes Sana and Amylyx

Pediatric cancer treatments threatened by a new FDA policy

leisure time

Wikipedia

focus

Affirmative action in medical school literally saved lives

Disappointing trial forces Pfizer to pivot on obesity medicine plans

Psychedelics group wrestles with new pharma identity

The EPA's new lead rule: How one expert crunched the numbers

Anesthesiologist group: stop taking Ozempic before surgery

Female surgeons have lower rates of long

Activists slam private health insurers over coverage restrictions

ReNAgade cuts staff seven months after raising $300 million

Affirmative action in medical school literally saved lives

What's changing in Medicare's open enrollment this year?

focus

How should state employee insurance handle Wegovy?

European regulators consider appeal over Amylyx ALS drug

Readout LOUD podcast: Merger Mondays, Ozempic panic

STAT Readout Newsletter: Today in biotech, life science news

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

Researchers CRISPR chickens in bid to protect them from bird flu

focus

knowledge

explore

hotspot